Tirzepatide
EhBuddy Research-Grade Tirzepatide — Available in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg, 45mg, 50mg, 60mg, 80mg, 100mg
Tirzepatide is a groundbreaking dual GLP-1/GIP receptor agonist that has reshaped metabolic and obesity research. Research models demonstrate up to 22.5% body weight reduction, significant glycaemic improvement, and beneficial effects on cardiovascular risk markers — making it one of the most studied compounds in modern metabolic research.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
Mazdutide
EhBuddy Research-Grade Mazdutide — Available in 5mg, 10mg
Mazdutide (IBI362) is a novel dual GLP-1/glucagon receptor agonist under active clinical investigation for obesity and type 2 diabetes. Phase 2 research data demonstrates exceptional body weight reduction and glycaemic improvements, combining the appetite-suppressing power of GLP-1 with glucagon's thermogenic and lipolytic effects.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
Survodutide
EhBuddy Research-Grade Survodutide
Survodutide (BI 456906) is an investigational dual GLP-1/glucagon receptor agonist in Phase 3 trials for obesity and NASH. Research data from the LIGHT UP trials demonstrates substantial body weight reduction along with significant improvements in liver histology — making it one of the most promising compounds in NASH research alongside metabolic syndrome.
Reconstitution: Bacteriostatic Water (BAC Water) or Sterile Water required.
FOR RESEARCH USE ONLY (RUO). Not approved for human or veterinary use. Intended for in vitro and laboratory research only. EhBuddy Peptides assumes no liability for misuse.
